Aside from non-coding RNAs, mRNAs detected in CLL EVs also constitute great biomarkers, with a signature including some BCR specific kinases and apoptosis regulators (LYN, SYK, MAPK, and BCL2) [46]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.